SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

NCT00436293 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

NCT05570422 ·Status: RECRUITING ·Phase: PHASE1

Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck

NCT00139243 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial

NCT07003620 ·Status: RECRUITING ·Phase: PHASE2

Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients

NCT06442709 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT05552807 ·Status: UNKNOWN ·Phase: PHASE1

Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00139269 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

NCT00589186 ·Status: UNKNOWN ·Phase: PHASE2

Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer

NCT05933889 ·Status: RECRUITING

Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer

NCT02079324 ·Status: COMPLETED ·Phase: PHASE1

Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00139230 ·Status: COMPLETED ·Phase: PHASE2

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

NCT02119559 ·Status: UNKNOWN ·Phase: NA

E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck

NCT01332266 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT00805012 ·Status: TERMINATED ·Phase: PHASE2

Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC

NCT07040072 ·Status: RECRUITING ·Phase: PHASE1

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT01154920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

NCT03333694 ·Status: TERMINATED ·Phase: PHASE1

Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma

NCT04146181 ·Status: UNKNOWN ·Phase: PHASE2

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

NCT02474368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma

NCT05328024 ·Status: RECRUITING

Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer

NCT00527982 ·Status: TERMINATED ·Phase: PHASE2

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT01427205 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

NCT00116909 ·Status: COMPLETED ·Phase: PHASE2

EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer

NCT00049140 ·Status: COMPLETED ·Phase: PHASE2

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

NCT04396886 ·Status: COMPLETED ·Phase: PHASE2